2017 annual financial data
Xenon Pharmaceuticals 2017 Operating margin
Direct answer
Operating margin was -10,474.28%.
Operating income was -32,575,000 USD and net income was -30,704,000 USD.
Operating cash flow was -28,726,000 USD.
Get free Xenon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 311,000 USD
- Operating income
- -32,575,000 USD
- Net income
- -30,704,000 USD
- Operating cash flow
- -28,726,000 USD